https://curemydisease.com/studies/dreamm-2-belantamab-for-multiple-myeloma-nct03525678-554
DREAMM 2: Belantamab for Multiple Myeloma (NCT03525678)
A phase 2 study testing two doses of belantamab mafodotin in adults with advanced multiple myeloma who have tried multiple prior treatments. NCT ID:...
multiple myelomadreamm